Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00116558 · ClinicalTrials.gov registry record · NA
Early Treatment of Amyotrophic Lateral Sclerosis (ALS) With Nutrition and Non-Invasive Positive Pressure Ventilation
A NA study of Amyotrophic Lateral Sclerosis, sponsored by Edward Kasaraskis.
- Completed
- Registry status
- NA
- Development phase
- 153
- Enrollment target
- 12
- Study locations
NCT00116558 is a NA study of Amyotrophic Lateral Sclerosis that has completed, run by Edward Kasaraskis. The registered enrollment target is 153 participants, below the 896-participant average among 102 other Amyotrophic Lateral Sclerosis trials with a reported enrollment target (83% lower). The trial reports 12 study locations across 9 states.
The verdict
NCT00116558, a NA study of Amyotrophic Lateral Sclerosis, has completed, sponsored by Edward Kasaraskis.
- COMPLETED
- Registry status
- NA
- Development phase
- 153 participants
- Enrollment target
- 12
- Study locations
Study Summary
The purposes of the study are to determine the energy balance and evaluate the nutritional status of patients with ALS, and to investigate the use of NIPPV as respiratory support to treat patients with ALS.
Conditions Studied
Interventions
- DEVICE Early NIPPV
- DEVICE Standard NIPPV
Study Locations (12)
New York
- Beth Israel - New York
- Columbia University - New York
- SUNY - Syracuse
Pennsylvania
- Pennsylvania State University - Hershey
- Drexel University - Philadelphia
Colorado
- University of Colorado - Denver
Florida
- University of Miami - Miami
Kentucky
- University of Kentucky - Lexington
Michigan
- Henry Ford Hospital - Detroit
Texas
- University of Texas-San Antonio - San Antonio
Utah
- University of Utah - Salt Lake City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 153 participants |
| Start Date | 2004-08-01 |
| Est. Completion | 2012-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00116558
The ClinicalTrials.gov registry entry for NCT00116558 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 153 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 896-participant average among 102 other Amyotrophic Lateral Sclerosis trials with a reported enrollment target (83% lower). The listed sponsor is Edward Kasaraskis, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Amyotrophic Lateral Sclerosis appearing as the primary indexed condition, and to 2 interventions - of which Early NIPPV is the first listed.
NCT00116558 reports 12 study locations spanning 9 distinct geographic areas - top geographies include New York, Pennsylvania, Colorado.
Frequently Asked Questions
What is clinical trial NCT00116558 about?
NCT00116558 is a clinical study titled "Early Treatment of Amyotrophic Lateral Sclerosis (ALS) With Nutrition and Non-Invasive Positive Pressure Ventilation". The purposes of the study are to determine the energy balance and evaluate the nutritional status of patients with ALS, and to investigate the use of NIPPV as respiratory support to treat patients with ALS.
What is the current status of trial NCT00116558?
This trial is currently completed. It is a NA study. The enrollment target is 153 participants. The study started on 2004-08-01. Estimated completion is 2012-01.
What conditions does trial NCT00116558 study?
This clinical trial studies the following conditions: Amyotrophic Lateral Sclerosis.
What interventions are being tested in trial NCT00116558?
The interventions under investigation include: Early NIPPV (DEVICE), Standard NIPPV (DEVICE).
Who is sponsoring clinical trial NCT00116558?
This trial is sponsored by Edward Kasaraskis, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00116558 being conducted?
This trial has 12 study locations across Colorado, Florida, Kentucky, Michigan, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Amyotrophic Lateral Sclerosis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Feasibility of the BrainGate2 Neural Interface System in Persons With Tetraplegia (BG-Speech-02)
RECRUITING · NA
-
Assessing Perceptual Effects of Interactive Tasks
RECRUITING · NA
-
Spinal Cord Associative Plasticity for ALS
RECRUITING · NA
-
Effects of Whole-body Electrical Muscle Stimulation Exercise on Adults With Neuromuscular Disease
RECRUITING · NA
-
Oral Intake of Enteral Nutrition Formula Preceding Placement and Feeding Via GTube and Its Impact on Formula Intolerance in pALS
RECRUITING · NA
-
Precise Robotically IMplanted Brain-Computer InterfacE
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.